tiprankstipranks
OncoCyte Corp (DE:7OC)
FRANKFURT:7OC

OncoCyte (7OC) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
OncoCyte Corp’s (7OC) Moving Averages Convergence Divergence (MACD) indicator is -0.58, suggesting OncoCyte Corp is a Buy.
OncoCyte Corp’s (7OC) 20-Day exponential moving average is 2.75, while OncoCyte Corp’s (7OC) share price is €0.178, making it a Sell.
OncoCyte Corp’s (7OC) 50-Day exponential moving average is 3.46, while OncoCyte Corp’s (7OC) share price is €0.178, making it a Sell.

OncoCyte (7OC) Pivot Points

Apr 29, 2024, 08:00 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.06
0.10
0.14
0.18
0.22
0.26
0.30
Fibonacci
0.10
0.13
0.15
0.18
0.21
0.23
0.26
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoCyte (7OC) Moving Averages

Apr 29, 2024, 08:00 AM
Period
Simple
Exponential
MA5
1.91Sell
1.49Sell
MA10
2.53Sell
2.19Sell
MA20
3.02Sell
2.75Sell
MA50
3.51Sell
3.46Sell
MA100
4.31Sell
4.57Sell
MA200
6.70Sell
7.41Sell
OncoCyte Corp’s (7OC) 10-Day exponential moving average is 2.19, while OncoCyte Corp’s (7OC) share price is €0.178, making it a Sell.
OncoCyte Corp’s (7OC) 100-Day exponential moving average is 4.57, while OncoCyte Corp’s (7OC) share price is €0.178, making it a Sell.
OncoCyte Corp’s (7OC) stock price is €0.178 and OncoCyte Corp’s (7OC) 50-day simple moving average is 3.51, creating a Sell signal.
OncoCyte Corp’s (7OC) stock price is €0.178 and OncoCyte Corp’s (7OC) 100-day simple moving average is 4.31, creating a Sell signal.
OncoCyte Corp’s (7OC) stock price is €0.178 and OncoCyte Corp’s (7OC) 200-day simple moving average is 6.70, creating a Sell signal.

OncoCyte (7OC) Technical Indicators

Apr 29, 2024, 08:00 AM
Name
Value
Implied Action
RSI (14)
22.00
Buy
STOCH (9,6)
17.46
Buy
STOCHRSI (14)
12.99
Buy
MACD (12,26)
-0.58
Buy
ADX (14)
24.67
Neutral
Williams %R
-98.89
Buy
CCI (14)
-331.88
Buy
ATR (14)
0.47
-
Ultimate Oscillator
29.13
Sell
ROC
-94.51
Sell
OncoCyte Corp’s (7OC) Relative Strength Index (RSI) is 22.00, creating a Buy signal.
OncoCyte Corp’s (7OC) Trend Strength Indicator (ADX) is 24.67, creating a Neutral signal.
OncoCyte Corp’s (7OC) Commodity Channel Index (CCI) is -331.88, creating a Buy signal.
OncoCyte Corp’s (7OC) Price Rate of Change (ROC) is -94.51, creating a Sell signal.

FAQ

Is 7OC a Buy, Hold, or Sell?
Based on 7OC’s technical indicators, 7OC is a Sell.
    What is 7OC’s RSI (14)?
    7OC’s RSI (14) is 22.00, which suggests 7OC is a Buy.
      What is 7OC’s MACD?
      7OC’s MACD is -0.58, which suggests 7OC is a Buy.
        What is 7OC’s 5-day moving average?
        7OC’s 5-day moving average is 1.91, which suggests 7OC is a Sell.
          What is 7OC’s 20-day moving average?
          7OC 20-day moving average is 3.02, which suggests 7OC is a Sell.
            What is 7OC’s 50-day moving average?
            7OC’s 50-day moving average is 3.51, which suggests 7OC is a Sell.
              What is 7OC’s 200-day moving average?
              7OC’s 200-day moving average is 6.70, which suggests 7OC is a Sell.
                What is 7OC’s Williams % R (14)?
                7OC’s Williams % R (14) is -98.89, which suggests 7OC is a Buy.
                  What is 7OC’s CCI (14)?
                  7OC’s CCI (14) is -331.88, which suggests 7OC is a Buy.
                    What is the share price of OncoCyte Corp?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis